Search

Your search keyword '"Kaufmann, Daniel E."' showing total 326 results

Search Constraints

Start Over You searched for: Author "Kaufmann, Daniel E." Remove constraint Author: "Kaufmann, Daniel E." Language english Remove constraint Language: english
326 results on '"Kaufmann, Daniel E."'

Search Results

1. Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity

3. Circulating proteins to predict COVID-19 severity

6. Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120

7. A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

8. An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells

9. A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses

10. Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients

11. Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

12. The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

15. Translocated microbiome composition determines immunological outcome in treated HIV infection

16. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

17. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity

20. Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy–Treated Individuals With Undetectable Viremia.

21. Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis.

23. Failed immune responses across multiple pathologies share pan-tumor and circulating lymphocytic targets

24. Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease

27. CXCL13 is a plasma biomarker of germinal center activity

28. Plasma SARS‐CoV‐2 RNA elimination and RAGE kinetics distinguish COVID‐19 severity.

29. Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine.

31. CD4 mimetics sensitize HIV-1-infected cells to ADCC

32. Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine

33. High-dimensional immunomonitoring models of HIV-1–specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control

34. Preserved Function of Regulatory T Cells in Chronic HIV-1 Infection Despite Decreased Numbers in Blood and Tissue

39. Epithelial adhesion molecules can inhibit HIV-1–specific CD8+ T-cell functions

40. Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination.

41. On-demand, hospital-based, severe acute respiratory coronavirus virus 2 (SARS-CoV-2) genomic epidemiology to support nosocomial outbreak investigations: A prospective molecular epidemiology study.

42. Excess BAFF Alters NR4As Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-Cells in the Context of HIV-1 Infection.

44. Dysfunctional HIV-Specific CD8+ T Cell Proliferation Is Associated with Increased Caspase-8 Activity and Mediated by Necroptosis

46. Transcriptional analysis of HIV-specific [CD8.sup.+] T cells shows that PD-1 inhibits T cell function by upregulating BATF

49. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

50. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection

Catalog

Books, media, physical & digital resources